CHIMERIC THERAPEUTICS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.019 AUD | +5.56% |
|
-17.39% | -45.71% |
| May. 22 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
| May. 20 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.0240 | 0.0290 | 0.0270 |
| Spread/Res. | -20.83% | -34.48% | -29.63% |
| Spread/Supp. | +18.75% | +18.75% | +18.75% |
| Support | 0.0160 | 0.0160 | 0.0160 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- CHM Stock
- Charts Chimeric Therapeutics Limited
